Navigation Links
Study Shows Bacterial Contamination Associated With Home-Laundered Surgical Scrubs Is Significantly Greater Than Other Options
Date:1/8/2010

NORCROSS, Ga., Jan. 8 /PRNewswire/ -- A study comparing the aerobic bacterial bioburden associated with surgical scrub attire shows significantly greater contamination among home-laundered attire than scrubs laundered by the healthcare facility, scrubs sent out by the facility to a third-party company for laundering, or single-use/disposable scrubs. In fact, home-laundered scrubs cleaned and ready to wear had as much bacteria present as facility-laundered, third-party laundered and single-use scrubs which had been worn for one day.

Conducted in the spring of 2009, the study was performed by Bioscience Laboratories, Inc., of Bozeman, Mont., and sponsored by Molnlycke Health Care US, LLC. A total of 80 surgical scrub garments, tops and bottoms, prior to use and after use in the operating room for a day, were collected from multiple healthcare facilities across the U.S. They comprised 10 sets of scrubs in each category: single-use; home-laundered; facility-laundered; and third-party laundered.

The study showed no statistically significant difference in bacterial contamination among facility-laundered, third-party laundered or single-use scrubs prior to use ("clean"), but revealed that the bioburden found on home-laundered scrubs prior to use ("clean") was significantly greater than on any of the other garments (facility-laundered, third-party laundered or single-use, non-woven) that had been worn for a day in the operating room.

"According to these results, a healthcare professional beginning his or her shift in home-laundered scrubs would essentially be wearing scrubs with the same quantity of bacteria as the scrubs of a healthcare professional finishing a shift in worn scrubs," said Heather Beitz, BA MEd, Director of Clinical Research for Molnlycke Health Care.

"This study indicates that home-laundering is not as effective as facility- or third-party laundering in decontaminating surgical scrub attire," Beitz explained. "Another option, of course, is single-use surgical attire. In addition to eliminating cross-contamination concerns as indicated in this study, single-use scrubs are durable and designed for daily use in a variety of surgical procedures and acute care needs and can reduce replacement costs," she added.

BARRIER® surgical scrub suits and jackets, manufactured by Molnlycke Health Care, are non-woven, single-use products that provide comfort with the soft feel of cotton. They are available in extended size ranges (S - 4XL), assuring a variety of fits. Departments benefiting from the use of BARRIER non-woven scrubs and jackets are trauma, isolation, ER, NICU (for parents), L&D (for fathers), cath and GI labs, oncology, and radiology/interventional radiology.

About Molnlycke Health Care US, LLC

Molnlycke Health Care US, LLC, consists of two divisions - Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel® surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens® and Hibistat® antiseptics); and BARRIER® protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.

SOURCE Molnlycke Health Care US, LLC


'/>"/>
SOURCE Molnlycke Health Care US, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... WASHINGTON , May 9, 2017  Demonstrating ... the board of directors for the Pharmaceutical Research ... criteria for membership. Biopharmaceutical companies will now have ... in order to be eligible to join PhRMA. ... criteria, the board is sending a clear message ...
(Date:5/9/2017)... Ore. , May 9, 2017  Semler ... that provides technology solutions to improve the clinical ... financial results for the first quarter ended March ... our products enable our customers to identify when ... to intervene before events like heart attacks or ...
(Date:5/8/2017)... FLINT, Mich. , May 8, 2017  Diplomat ... WRB Communications, Inc. ("WRB"), a health care ... . WRB specializes in relationship management ... organizations. WRB will ... of Diplomat,s commercialization support services for manufacturers, biotech firms, ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... May 23, 2017 , ... ... medical device sectors, today announced the winners of its 3rd Annual ELITE Awards. ... most influential people in the healthcare industry today. , Out of more than ...
(Date:5/23/2017)... ... 2017 , ... New England Journal Of Medicine Confirms Viability of Rory’s Regulations ... Rory Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt Rory’s ... ) today reported on a new study released on May 21, 2017 in the ...
(Date:5/23/2017)... ... May 23, 2017 , ... The National Council on ... to announce the organization’s Certified Strength Coach credential has earned accreditation from the ... program validates the competency of qualified candidates for jobs in the Strength and ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... ... Facial Plastic and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce a ... in building collagen and elastin in their face, neck, and body through a ...
(Date:5/23/2017)... NV (PRWEB) , ... May 23, 2017 , ... ... Dental Specialists, are educating patients on peri-implantitis in Las Vegas, NV, ... to receive a custom gum disease consultation and leading care for peri-implantitis, with ...
Breaking Medicine News(10 mins):